Taramasso, L., Ricci, E., Celesia, B., Bonfanti, P., Quirino, T., Squillace, N., et al. (2017). Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 41(5), e76-e79 [10.1016/j.clinre.2017.03.006].

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Bonfanti P.;Squillace N.;
2017

Lettera in rivista
Hepatitis C virus; Sofosbuvir/ledipasvir; Tenofovir
English
e76
e79
Taramasso, L., Ricci, E., Celesia, B., Bonfanti, P., Quirino, T., Squillace, N., et al. (2017). Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 41(5), e76-e79 [10.1016/j.clinre.2017.03.006].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/295882
Citazioni
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
Social impact